Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Topical eye β-blockers may cause hair loss.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Metabolic syndrome in kids and teens is linked to obesity and increases diabetes and heart disease risk; early lifestyle changes are crucial for management.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Electro-acupuncture may help treat PCOS in rats by changing brain DNA methylation.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.